Medical Technology Company President Convicted in $77 Million COVID-19 and Allergy Testing Scheme
A federal jury convicted the president of a Silicon Valley-based medical technology company yesterday of participating in a scheme to mislead investors, commit health care fraud, and pay illegal kickbacks in connection with the submission of over $77 million in false and fraudulent claims for COVID-19 and allergy testing.
Action Details
- Date:September 2, 2022
- Agency:U.S. Department of Justice
-
Enforcement Types:
- COVID-19,
- Criminal and Civil Actions